These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6536653)

  • 21. T-inducer lymphocytes, leukapheresis and the pathogenesis of rheumatoid arthritis.
    Wilder RL; Decker JL
    Clin Exp Rheumatol; 1983; 1(2):89-91. PubMed ID: 6241855
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphocyte subpopulations and immunoglobulins in blood in rheumatoid arthritis.
    Kapoor AK; Khan IU; Tuteja N; Dash UC; Jain UK; Siddiqui JS; Singh M; Bhushan V; Mehrotra RM; Bahuguna LM
    Indian J Med Res; 1981 Oct; 74():595-9. PubMed ID: 7338385
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lymphocytopheresis and plasmapheresis in rheumatoid arthritis].
    Dubrovina NA; Kalinin NN; Khotinian RI; Molchanova NP; Petrov MM
    Revmatologiia (Mosk); 1984; (3):9-12. PubMed ID: 6390635
    [No Abstract]   [Full Text] [Related]  

  • 24. An update on the status of the treatment of rheumatoid arthritis by lymphapheresis.
    Karsh J
    Int J Artif Organs; 1985 Jul; 8 Suppl 2():35-8. PubMed ID: 3876998
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune function in blood donors following short-term lymphocytapheresis.
    Blanchette VS; Dunne J; Steele D; McPhail S; Sklar S; Algom D; Richter MA; Rock G
    Vox Sang; 1985; 49(2):101-9. PubMed ID: 4036082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of thoracic duct drainage on lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis.
    Ueo T; Tanaka S; Tominaga Y; Ogawa H; Sakurami T
    Arthritis Rheum; 1979 Dec; 22(12):1405-12. PubMed ID: 518724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apheresis in rheumatoid arthritis.
    Hamblin TJ
    Int J Artif Organs; 1984 Jul; 7(4):229-30. PubMed ID: 6386698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical assessment of the immunoglobulin level in rheumatoid arthritis].
    Ianbaeva KhI; Isakhanov GI; Konstantinovskaia AA
    Ter Arkh; 1982; 54(12):56-8. PubMed ID: 6984236
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunocorrective therapy of rheumatoid arthritis by means of lymphocytoplasmopheresis].
    Miterev IuG; Nasonova VA; Dubrovina NA; Khotinian RI; Speranskiĭ AI
    Sov Med; 1982; (5):70-5. PubMed ID: 6981213
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis.
    Wallace DJ; Goldfinger D; Gatti R; Lowe C; Fan P; Bluestone R; Klinenberg JR
    Arthritis Rheum; 1979 Jul; 22(7):703-10. PubMed ID: 454499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular depletion by apheresis.
    Strauss RG; Huestis DW; Wright DG; Hester JP
    J Clin Apher; 1983; 1(3):158-65. PubMed ID: 6546054
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulin.
    Becker H; Mitropoulou G; Helmke K
    Klin Wochenschr; 1989 Mar; 67(5):286-90. PubMed ID: 2565412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis.
    Snowden JA; Biggs JC; Milliken ST; Fuller A; Staniforth D; Passuello F; Renwick J; Brooks PM
    Bone Marrow Transplant; 1998 Dec; 22(11):1035-41. PubMed ID: 9877264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic lymphapheresis in leukostasis-induced priapism].
    Strobel E; Howe J; Bäcker U; Ernst G; Mempel M
    Dtsch Med Wochenschr; 1987 Dec; 112(51-52):1984-5. PubMed ID: 3691330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukapheresis in rheumatoid arthritis. Association of clinical improvement with reversal of anergy.
    Wahl SM; Wilder RL; Katona IM; Wahl LM; Allen JB; Scher I; Decker JL
    Arthritis Rheum; 1983 Sep; 26(9):1076-84. PubMed ID: 6615562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The current status of therapeutic apheresis in the management of rheumatoid arthritis.
    Wallace DJ; Goldfinger D; Klinenberg JR
    Prog Clin Biol Res; 1982; 106():27-32. PubMed ID: 6757943
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma exchange for rheumatoid arthritis.
    Seror R; Pagnoux C; Guillevin L
    Transfus Apher Sci; 2007 Apr; 36(2):195-9. PubMed ID: 17499763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocytapheresis and rheumatoid arthritis: comment on the article by Hidaka et al.
    Wallace DJ
    Arthritis Rheum; 1999 Oct; 42(10):2255-6. PubMed ID: 10524704
    [No Abstract]   [Full Text] [Related]  

  • 39. Leukapheresis and pathogenetic mechanisms in rheumatoid arthritis.
    Wilder RL; Malone DG; Yarboro CH; Berkebile C; Haraoui B; Allen JB; Wahl SM
    J Clin Apher; 1984; 2(1):112-8. PubMed ID: 6336086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apheresis and rheumatoid arthritis.
    Decker JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):666-7. PubMed ID: 6846981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.